Helen Brady

2.6k total citations
31 papers, 2.1k citations indexed

About

Helen Brady is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Helen Brady has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Genetics and 8 papers in Hematology. Recurrent topics in Helen Brady's work include Virus-based gene therapy research (6 papers), Estrogen and related hormone effects (6 papers) and RNA Research and Splicing (6 papers). Helen Brady is often cited by papers focused on Virus-based gene therapy research (6 papers), Estrogen and related hormone effects (6 papers) and RNA Research and Splicing (6 papers). Helen Brady collaborates with scholars based in United States, Switzerland and Austria. Helen Brady's co-authors include William S.M. Wold, George W. Muller, Ann E. Tollefson, Peter Schäfer, Kyle Chan, Dominique Verhelle, Kristen Jensen-Pergakes, Bernd Stein, L R Gooding and Lynne W. Elmore and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Helen Brady

30 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Brady United States 19 1.3k 689 488 449 435 31 2.1k
Robert M. Kay United States 18 1.3k 1.0× 371 0.5× 484 1.0× 782 1.7× 406 0.9× 18 2.6k
Christine J. Farr United Kingdom 29 2.0k 1.5× 364 0.5× 604 1.2× 153 0.3× 375 0.9× 60 2.8k
N Kitamura Japan 24 1.3k 1.0× 268 0.4× 286 0.6× 415 0.9× 321 0.7× 36 2.8k
Nechama Haran‐Ghera Israel 28 813 0.6× 475 0.7× 462 0.9× 858 1.9× 594 1.4× 125 2.4k
Karl‐Heinz Klempnauer Germany 30 3.1k 2.4× 352 0.5× 483 1.0× 541 1.2× 832 1.9× 91 4.0k
Daniel S. Pereira Brazil 22 885 0.7× 251 0.4× 338 0.7× 237 0.5× 440 1.0× 76 1.7k
Nancy J. Zeleznik‐Le United States 32 3.2k 2.4× 1.3k 1.9× 335 0.7× 559 1.2× 460 1.1× 68 4.2k
Sophia Derdak Austria 21 800 0.6× 334 0.5× 198 0.4× 630 1.4× 272 0.6× 58 1.9k
Kumkum Saxena United States 10 1.4k 1.1× 285 0.4× 141 0.3× 287 0.6× 230 0.5× 16 2.2k
Suzana S. Couto United States 24 1.2k 0.9× 434 0.6× 152 0.3× 451 1.0× 644 1.5× 55 2.1k

Countries citing papers authored by Helen Brady

Since Specialization
Citations

This map shows the geographic impact of Helen Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Brady more than expected).

Fields of papers citing papers by Helen Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Brady. The network helps show where Helen Brady may publish in the future.

Co-authorship network of co-authors of Helen Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Brady. A scholar is included among the top collaborators of Helen Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Brady. Helen Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petry, Natasha, et al.. (2025). Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacy. Pharmacogenomics. 26(1-2). 23–29.
2.
Schäfer, Peter, Anastasia Parton, Lori Capone, et al.. (2014). Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cellular Signalling. 26(9). 2016–2029. 248 indexed citations
3.
Lopez‐Girona, Antonia, Daniel Heintel, Derek Mendy, et al.. (2011). Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response. British Journal of Haematology. 154(3). 325–336. 137 indexed citations
4.
Mamidipudi, Vidya, Tao Shi, Helen Brady, et al.. (2011). Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells. Cancer Chemotherapy and Pharmacology. 69(4). 965–976. 8 indexed citations
5.
Hollenbach, Paul W., Aaron Nguyen, Helen Brady, et al.. (2010). A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines. PLoS ONE. 5(2). e9001–e9001. 288 indexed citations
6.
Escoubet‐Lozach, Laure, Kristen Jensen-Pergakes, Helen Brady, et al.. (2009). Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism. Cancer Research. 69(18). 7347–7356. 139 indexed citations
7.
Parseval, Laure A Moutouh-de, Dominique Verhelle, Emilia Glezer, et al.. (2008). Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. Journal of Clinical Investigation. 118(1). 248–258. 141 indexed citations
8.
Gaidarova, Svetlana, Laura G. Corral, David Young, et al.. (2008). Lenalidomide Enhances Anti-Tumor Effect of γδ T Cells against Mantle Cell Lymphoma. Blood. 112(11). 2616–2616. 14 indexed citations
9.
Ferguson, Gregory D., Kristen Jensen-Pergakes, Normand Richard, et al.. (2007). Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2. Journal of Clinical Immunology. 27(2). 210–220. 21 indexed citations
10.
McKie, Jeffrey A., Shripad S. Bhagwat, Helen Brady, et al.. (2004). Lead identification of a potent benzopyranone selective estrogen receptor modulator. Bioorganic & Medicinal Chemistry Letters. 14(13). 3407–3410. 33 indexed citations
11.
Park, Jin Mo, Helen Brady, Maria Grazia Ruocco, et al.. (2004). Targeting of TAK1 by the NF-κB protein Relish regulates the JNK-mediated immune response in Drosophila. Genes & Development. 18(5). 584–594. 149 indexed citations
12.
Brady, Helen, et al.. (2004). Novel Immunomodulatory Drugs (IMiDs®): A Potential, New Therapy for β-Hemoglobinopathies.. Blood. 104(11). 3740–3740. 1 indexed citations
13.
Brady, Helen, Matthew Hickman, Normand Richard, et al.. (2002). Differential Response of Estrogen Receptors α and β to SP500263, a Novel Potent Selective Estrogen Receptor Modulator. Molecular Pharmacology. 61(3). 562–568. 29 indexed citations
14.
Stein, Bernd, et al.. (1996). Cloning and Characterization of MEK6, a Novel Member of the Mitogen-activated Protein Kinase Kinase Cascade. Journal of Biological Chemistry. 271(19). 11427–11433. 165 indexed citations
15.
Brady, Helen, Abraham Scaria, & William S.M. Wold. (1992). Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. Journal of Virology. 66(10). 5914–5923. 19 indexed citations
16.
Carlin, Cathleen R., et al.. (1989). Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell. 57(1). 135–144. 125 indexed citations
17.
Gooding, L R, Lynne W. Elmore, Ann E. Tollefson, Helen Brady, & William S.M. Wold. (1988). A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell. 53(3). 341–346. 207 indexed citations
18.
Brady, Helen & William S.M. Wold. (1987). Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. Nucleic Acids Research. 15(22). 9397–9416. 30 indexed citations
19.
Bhat, Bheem M., Helen Brady, Michael Pursley, & William S.M. Wold. (1986). Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus. Journal of Molecular Biology. 190(4). 543–557. 29 indexed citations
20.
Bhat, Bheem M., Helen Brady, & William S.M. Wold. (1985). Virus Deletion Mutants That Affect a 3′ Splice Site in the E3 Transcription Unit of Adenovirus 2. Molecular and Cellular Biology. 5(9). 2405–2413. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert M. Kay Breakdown of academic impact, for papers by Christine J. Farr Breakdown of academic impact, for papers by N Kitamura Breakdown of academic impact, for papers by Nechama Haran‐Ghera Breakdown of academic impact, for papers by Karl‐Heinz Klempnauer Breakdown of academic impact, for papers by Daniel S. Pereira Breakdown of academic impact, for papers by Nancy J. Zeleznik‐Le Breakdown of academic impact, for papers by Sophia Derdak Breakdown of academic impact, for papers by Kumkum Saxena Breakdown of academic impact, for papers by Suzana S. Couto
Rankless by CCL
2026